Close mobile menu×
Close mobile menu

Lorna M. Dove, MD, MPH

Board Certifications: 
Gastroenterology, Transplant Hepatology, Internal Medicine
Accepting New Patients
Virtual Visits/Telehealth
Profile Headshot

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Credentials & Experience

Board Certifications

  • Gastroenterology
  • Transplant Hepatology
  • Internal Medicine

Clinical Expertise

  • Autoimmune Liver Disease
  • Cirrhosis
  • Hepatocellular Carcinoma
  • Liver Disease
  • Liver Disease in HIV
  • Liver Transplant
  • Non-Alcoholic Fatty Liver Disease
  • Viral Hepatitis

Education & Training

  • Columbia University College of Physicians and Surgeons
  • Residency: University of California-San Francisco Medical Center
  • Fellowship: University of California-San Francisco Medical Center

Honors & Awards

  • 2019 Member Columbia University Vagelos College of Physicians and Surgeons Academy of Clinical Excellence
  • 2017 NYP Physician of the Year Award
  • 2010 Ewig Clinical Scholar, Teaching Award Dept. of Medicine-Columbia University
  • 2006 Nominee Columbia University Kimberg Faculty Teaching Award Nominee
  • 2002 Nominee AMWA Gender Equity in Teaching Award
  • 2001 UCSF Teaching Award for Outstanding Lecturer
  • 1996 Robert Wood Johnson Minority Faculty Development Fellowship
  • 1993 Alpha Omega Alpha Teaching Award, University of California at San Francisco

About Lorna Dove

Academic Titles

  • Professor of Medicine (in Surgery) at CUMC

Administrative Positions

  • Medical Director, Adult Liver Transplant - Center for Liver Disease and Transplantation, CUMC
  • Director of Clinical Hepatology

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian / Weill Cornell Medical Center

Gender

  • Female

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs

Amida Care

  • Special Needs

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West (National)
  • HMO
  • POS
  • PPO

Elderplan

  • Medicare Managed Care

Emblem/GHI

  • Medicare Managed Care
  • PPO

Empire Blue Cross/Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Health First

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Health Insurance Plan of NY (HIP)

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Health Plus - Amerigroup

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

United Health Care

  • Columbia Employee POS
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE SelectHealth

  • Medicare Managed Care
  • Select Health
  • Special Needs

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
622 West 168th Street
PH, Floor 14
New York, New York 10032
Primary
3
1375 Washington Ave, Suite 101
Albany, New York 12206
Phone:

Research

Hepatitis C and Liver Transplantation

Selected Publications

Original Peer Reviewed Articles

  1. Verna E, Shetty K, Lukose T, Terry N, Mentore K, Olsen, SK, Fox AN, Dove, LM, Brown RS. High Post-Transplant Virological Response in Hepatitis C Virus Infected Patients Treated with Pretransplant Protease Inhibitor-based Triple Therapy. Liver International. 35(2):510-,2015, Feb.
  2. Farr M, Mitchell J, Lippel M, Kato TS, Jin Z, Ippolito P, Dove L, Jorde UP, Takayama H, Emond J, Naka Y, Mancini D, Lefkowitch JH, Schulze PC. Combination of Liver biopsy with MELD-XI Scores for Post-Transplant Outcome Prediction in Patients with Advanced Heart Failure and Suspected Liver Dysfunction. J Heart Lung Transplant. 34(7): 873-82. 2015, Jul.
  3. Siegel AB, El-Khoueiry AB, Finn RS, Guthrie KA, Goyal A, Venook AP, Blanke CD, Verna EC, Dove, L, Emond J, Kato T, Samstein B, Busuttil R, Remotti H, Coffey A, Brown RS JR. Phase I Trial of Sorafenib following Liver Transplantation in Patients with High-Risk Hepatocellular carcinoma. Liver Cancer. 4(2): 115-25.2013 March.
  4. Hsu CC, Goyal A, Iuga A, Krishnamurthy S, Lee V, Verna EC, Wang S, Chen FN, Rodriguez, R, Emond J, Berk P, Lefkowitch, J, Dove L, Brown RS Jr. Siegel AB. Elevated CA19-9 Is Associated with Increaed Mortality IN a Prospective Cohort Of Hepatocellular Carcinoma Patients. Clin Transl Gastreonterology.6: e74. 2015 Feb.
  5. Verna EC, Shetty K, Lukose T, Terry N, Mentore K, Olsen SK, Fox AN, Dove LM, Brown RS. High Post-Transplant Virological Response in Hepatitis C Virus Infected Patients Treated with PreTransplant Protease Inhibitor-Based Triple Therapy. Liver International 35(2):510-7,2015 Feb.
  6. Siegel AB, Conner K, Wang S, Jacobson JS, Hershman DL, Hidalgo R, Verna EC, Halazun K, Brubaker W, Zaretsky J, Moniodis A, Delgado-Cruzata L, Dove L, Emond J, Kato T, Brown RS Jr., Neugut A. Smoking and Hepatocellular Carcinoma Mortality. Exp Ther Med. 2012Jan; 3(1): 124-128.
  7. Siegel A, Lim EA. Wang S. Brubaker W, Rodriguez RD. Goyal A. Jacobson J. Hershman DL, Verna EC, Zaretsky, J, Halazun K, Dove L, Brown, RS Jr. Neugut A, Kato T, Remotti H, Coppleson Y, Emond JC. Diabetes, Body Mass Index and Outcomes in Hepatocellular Carcinoma Patients undergoing Liver Transplantation. Transplantation. 94(5): 539-42, 2012 Sep.
  8. Terrault N, Roland ME, Schiano T, Dove L, Wong MT, et al. Outcomes of Liver Transplant Recipients with Hepatitis C and Human Immunodeficiency Virus Coinfection. Liver Transplantation. 18(6): 716-726, 2012, Jun.
  9. Talal A, Liu RC, Zeremski M, Dimova R, Dove L, Pearce D, Hassanein et al. Randomized Trial Comparing Dose Reduction and Growth Factor Supplementiaotn for Management of Hematological Side Effects in HIV/Hepatitis C virus Patients Receiving Pegylated-Interferon and Ribavirin. Jo Acquir Immune Defic Syndr. 58 (3): 261-8, 2011 Nov. 1
  10. Subramanian A. Sulkowski M. Barin B. Stablein D. Curry M. Nissen N. Dove L. Roland M. Florman S. Blumberg E. Stosor V. Jayaweera DT. Huprikar S. Fung J. Pruett T. Stock P. Ragni M. MELD Score is an Important Predictor of Pre-transplantation Mortality in HIV-Infected Liver Transplant Candidates. Gastroenterology. 138(1): 159-64, 2010 Jan.
  11. Coffin CS. Stock PG. Dove LM. Berg CL. Nissen NN. Curry MP. Ragni M. Regenstein FG. Sherman KE. Roland ME. Terrault NA. Virologic and Clinical Outcomes of Hepatitis B virus Infection in HIV-HBV Coinfected Transplant Recipients. American Journal of Transplantation. 10(5): 1268-75, 2010 May.
  12. Siegel AB. Wang S. Jacobson JS. Hershman DL. Lim EA. Yu J. Ferrante L. Devaraj KM. Remotti H. Scrudato S. Halazun K. Emond J. Dove L. Brown RS Jr. Neugut AI. Obesity and Microvascular Invasion in Hepatocellular Carcinoma. Cancer Investigation. 28(10): 1063-9, 2010 Dec.